Large Australian twin study found cannabis use, abuse, and early onset were all highly heritable
In 3,824 young adult twins, heritability estimates ranged from 72-80% for multiple cannabis phenotypes including early opportunity to use, early onset use, regular use, and DSM abuse/dependence.
Quick Facts
What This Study Found
Researchers interviewed 3,824 young adult twins born 1972-1979 about cannabis and other drug use. Cannabis use was remarkably common: 75.2% of males and 64.7% of females reported some lifetime use, while 24.5% of males and 11.8% of females met criteria for cannabis abuse or dependence.
Genetic analysis revealed consistently high heritability across cannabis phenotypes: early opportunity to use (72%), early onset use by age 16 (80%), using 11+ times lifetime (76%), and DSM abuse/dependence (72%). These were among the highest heritability estimates for any substance use phenotype.
Early age of cannabis onset was strongly associated with subsequent use of other illicit drugs and drug abuse/dependence, with some evidence that this was mediated by increased exposure to and opportunity to use other drugs.
Key Numbers
3,824 twins, 3,567 families. Male cannabis use: 75.2%. Female: 64.7%. Male abuse/dependence: 24.5%. Female: 11.8%. Heritability: 72-80% across phenotypes.
How They Did This
Twin study with 3,824 young adult twins and siblings from 3,567 families. Structured interviews assessed cannabis use stages, other drug use, and psychiatric conditions. Bivariate genetic modeling estimated heritability of cannabis phenotypes.
Why This Research Matters
The consistently high heritability (72-80%) across cannabis use stages meant that genetic factors strongly influence not just whether someone tries cannabis but also whether they develop problems with it. This has implications for prevention (targeting genetically vulnerable individuals) and destigmatization (addiction as biological vulnerability rather than moral failing).
The Bigger Picture
The finding that even opportunity to use cannabis was 72% heritable challenged simplistic models of drug use as purely environmental. Genetic factors influenced not just pharmacological responses but the social environments and personality traits that lead to drug exposure.
What This Study Doesn't Tell Us
Australian twin sample may not generalize to other populations. Self-reported drug use. Twin studies assume equal environments for identical and fraternal twins. High prevalence of cannabis use in this cohort (born 1970s) may affect generalizability to other eras.
Questions This Raises
- ?Which specific genes drive the high heritability?
- ?Can genetic risk scores predict who will develop cannabis problems?
- ?Does the high heritability of "opportunity to use" reflect gene-environment correlation (genetically influenced social environment selection)?
Trust & Context
- Key Stat:
- 72-80% heritability across all cannabis use phenotypes
- Evidence Grade:
- Large twin study with structured interviews. Well-powered for genetic modeling. Standard twin study limitations apply.
- Study Age:
- Published in 2012. Genome-wide association studies have since begun identifying specific genetic variants underlying these heritability estimates.
- Original Title:
- An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology.
- Published In:
- Twin research and human genetics : the official journal of the International Society for Twin Studies, 15(5), 631-41 (2012)
- Authors:
- Lynskey, Michael T(26), Agrawal, Arpana(39), Henders, Anjali(2), Nelson, Elliot C, Madden, Pamela A F, Martin, Nicholas G
- Database ID:
- RTHC-00585
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Is cannabis addiction genetic?
This study found genetics explained 72% of the variation in cannabis abuse/dependence among twins. This is among the highest heritability estimates for any substance. However, genetics is not destiny: 72% genetic influence means 28% is environmental, and not all genetically vulnerable individuals develop problems.
Does early cannabis use lead to other drug use because of genetics?
Partly. Early cannabis onset strongly predicted other drug use, but some of this was explained by increased opportunity and exposure to other drugs rather than a direct pharmacological gateway effect. Shared genetic factors that promote risk-taking may also drive both early cannabis use and openness to other drugs.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-00585APA
Lynskey, Michael T; Agrawal, Arpana; Henders, Anjali; Nelson, Elliot C; Madden, Pamela A F; Martin, Nicholas G. (2012). An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology.. Twin research and human genetics : the official journal of the International Society for Twin Studies, 15(5), 631-41. https://doi.org/10.1017/thg.2012.41
MLA
Lynskey, Michael T, et al. "An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology.." Twin research and human genetics : the official journal of the International Society for Twin Studies, 2012. https://doi.org/10.1017/thg.2012.41
RethinkTHC
RethinkTHC Research Database. "An Australian twin study of cannabis and other illicit drug ..." RTHC-00585. Retrieved from https://rethinkthc.com/research/lynskey-2012-an-australian-twin-study
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.